ABIOMED - Delisted Stock
ABIOMED cannot be verified against its exchange. It appears that ABIOMED is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Note that a delisted financial instrument is a security that has been removed from its exchange and is no longer traded publicly. This can occur for various reasons, such as bankruptcy, merger, or failure to meet exchange listing requirements. Delisted instruments can still trade in the over-the-counter (OTC) market, but they are typically less liquid and carry higher risk compared to assets listed on a major exchange. Check all delisted instruments accross multiple markets.
ABIOMED Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. ABIOMED market risk premium is the additional return an investor will receive from holding ABIOMED long position in a well-diversified portfolio.
| Mean Deviation | 0.1348 | |||
| Standard Deviation | 0.2106 | |||
| Variance | 0.0443 | |||
| Downside Variance | 0.0181 |
Try Other Suggestions
ABIOMED Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ABIOMED stock to make a market-neutral strategy. Peer analysis of ABIOMED could also be used in its relative valuation, which is a method of valuing ABIOMED by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ABIOMED Corporate Management
| Michael Howley | VP and General Manager of Global Sales | Profile | |
| Thorsten Siess | Ex Officer | Profile | |
| Ingrid Ward | Director Relations | Profile | |
| Matthew Plano | Ex Integration | Profile |
Still Interested in ABIOMED?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |